Triumph Capital Management bought a new stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG – Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 19,725 shares of the company’s stock, valued at approximately $1,119,000.
Several other hedge funds also recently added to or reduced their stakes in the business. Allworth Financial LP grew its position in BrightSpring Health Services by 179.3% during the 2nd quarter. Allworth Financial LP now owns 405 shares of the company’s stock worth $28,000 after purchasing an additional 260 shares during the period. State of Wyoming lifted its holdings in shares of BrightSpring Health Services by 4.5% in the 1st quarter. State of Wyoming now owns 7,776 shares of the company’s stock valued at $331,000 after buying an additional 336 shares during the period. IFP Advisors Inc lifted its holdings in shares of BrightSpring Health Services by 204.5% in the 2nd quarter. IFP Advisors Inc now owns 606 shares of the company’s stock valued at $42,000 after buying an additional 407 shares during the period. Arizona State Retirement System lifted its holdings in shares of BrightSpring Health Services by 1.1% in the 2nd quarter. Arizona State Retirement System now owns 39,976 shares of the company’s stock valued at $2,788,000 after buying an additional 423 shares during the period. Finally, Moran Wealth Management LLC boosted its stake in shares of BrightSpring Health Services by 9.0% in the first quarter. Moran Wealth Management LLC now owns 6,925 shares of the company’s stock worth $295,000 after buying an additional 572 shares during the last quarter.
Analysts Set New Price Targets
BTSG has been the topic of several analyst reports. UBS Group raised their target price on BrightSpring Health Services from $63.00 to $85.00 and gave the stock a “buy” rating in a report on Wednesday, July 8th. BTIG Research reissued a “buy” rating and issued a $90.00 price target on shares of BrightSpring Health Services in a report on Thursday, August 13th. TD Cowen upped their price objective on BrightSpring Health Services from $65.00 to $81.00 and gave the stock a “buy” rating in a research report on Thursday, June 18th. Morgan Stanley raised their price objective on shares of BrightSpring Health Services from $71.00 to $80.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Finally, Zacks Research lowered shares of BrightSpring Health Services from a “strong-buy” rating to a “hold” rating in a report on Friday, October 2nd. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $70.71.
BrightSpring Health Services Price Performance
Shares of BTSG stock traded up $0.70 during mid-day trading on Wednesday, hitting $63.35. 1,381,657 shares of the stock were exchanged, compared to its average volume of 2,888,013. BrightSpring Health Services, Inc. has a 52-week low of $29.01 and a 52-week high of $73.75. The company has a quick ratio of 1.22, a current ratio of 1.59 and a debt-to-equity ratio of 1.06. The company has a market cap of $12.53 billion, a PE ratio of 38.16, a price-to-earnings-growth ratio of 0.82 and a beta of 1.87. The firm has a fifty day moving average of $59.72 and a 200 day moving average of $59.11.
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last announced its quarterly earnings results on Friday, July 31st. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.05. The firm had revenue of $3.87 billion during the quarter, compared to analyst estimates of $3.66 billion. BrightSpring Health Services had a return on equity of 16.73% and a net margin of 2.55%. BrightSpring Health Services’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.22 EPS. Research analysts anticipate that BrightSpring Health Services, Inc. will post 1.64 earnings per share for the current year.
About BrightSpring Health Services
BrightSpring Health Services, Inc is a U.S. provider of pharmacy and health services focused on individuals with complex or chronic medical needs. The company delivers care across home and community-based settings, serving older adults, people with disabilities, and patients requiring specialized support.
Its services include pharmacy care through PharMerica, home health and hospice, primary and urgent care, behavioral health, rehabilitation, and personal care. BrightSpring also provides residential and community-based services, including assistance with daily living, clinical support, and care coordination for individuals who need ongoing support outside traditional hospital settings.
The company was formed in 2019 through the combination of PharMerica and ResCare.
Further Reading
- Five stocks we like better than BrightSpring Health Services
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.
